Show simple item record

dc.creatorVucelić, Dragica
dc.creatorJesić, Rada
dc.creatorJovičić, Snežana
dc.creatorZivotić, Maja
dc.creatorGrubor, Nikica
dc.creatorTrajković, Goran
dc.creatorCanić, Ivana
dc.creatorElezović, Ivo
dc.creatorAntović, Aleksandra
dc.date.accessioned2019-09-02T11:46:52Z
dc.date.available2019-09-02T11:46:52Z
dc.date.issued2015
dc.identifier.issn0049-3848
dc.identifier.urihttp://farfar.pharmacy.bg.ac.rs/handle/123456789/2396
dc.description.abstractBackground: The Clauss fibrinogen method and thrombin clotting time (TCT) are still routinely used in patients with cirrhosis to define fibrinogen concentration and clotting potential. The thromboelastometric functional fibrinogen FIBTEM assay evaluates the strength of fibrin-based clots in whole blood, providing information on both quantitative deficit and fibrin polymerization disorders. Objective: To compare these three methods of assessing fibrinogen in patients with cirrhosis of different aetiologies, characterized by impairment in fibrinogen concentration as well as functional aberrance. Methods: Sixty patients with alcoholic and 24 patients with cholestatic cirrhosis were included (Child-Pugh score (CPs) A, n = 24; B, n = 32; C, n = 28). All parameters were compared with those from a control group. Maximum clot firmness (MCF) in the FIBTEM test was assessed in regard to its relevance in detection of qualitative fibrinogen disorders in comparison with results obtained by standard measurement methods, i.e. the Clauss fibrinogen method and TCT. Results: With increased cirrhosis severity, fibrinogen and FIBTEM-MCF levels significantly declined (p = 0.002), while TCT was significantly prolonged (p = 0.002). In all CPs groups, fibrinogen strongly correlated with FIBTEM-MCF (r = 0.77, r = 0.72, r = 0.74; p lt 0.001), while cross-correlations of other assays were highly variable. The prevalence of decreased FIBTEM-MCF values ( lt 9 mm) was significantly higher in advanced CPs categories (p = 0.027), whereby the highest prevalence was detected in patients with CPsC (10/16; 62.5%). Nine of the 16 patients with decreased FIBTEM-MCF values had also decreased fibrinogen levels, while in the remaining 7 patients fibrinogen levels were within the reference range, indicating the possible presence of qualitatively altered fibrinogen that could be detected by FIBTEM-MCF. Conclusions: FIBTEM-MCF may be considered as a reliable alternative to standard plasma fibrinogen measurement in cirrhotic patients, especially in evaluating fibrin polymerization disorders in these patients. Further studies are needed to evaluate the usefulness of this assay in predicting bleeding complications in cirrhotic patients as well as monitoring replacement treatment.en
dc.publisherPergamon-Elsevier Science Ltd, Oxford
dc.rightsrestrictedAccess
dc.sourceTohoku Journal of Experimental Medicine
dc.subjectFibrinogenen
dc.subjectStandard measurement methodsen
dc.subjectThromboelastometryen
dc.subjectCirrhosisen
dc.titleComparison of standard fibrinogen measurement methods with fibrin clot firmness assessed by thromboelastometry in patients with cirrhosisen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractВуцелић, Драгица; Елезовић, Иво; Aнтовић, Aлександра; Зивотић, Маја; Цанић, Ивана; Јовичић, Снежана; Јесић, Рада; Грубор, Никица; Трајковић, Горан;
dc.citation.volume135
dc.citation.issue6
dc.citation.spage1124
dc.citation.epage1130
dc.citation.other135(6): 1124-1130
dc.citation.rankM23
dc.identifier.wos000354497300016
dc.identifier.doi10.1016/j.thromres.2015.04.003
dc.identifier.pmid25900310
dc.identifier.scopus2-s2.0-84929512484
dc.identifier.rcubconv_3308
dc.type.versionpublishedVersion


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record